• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Symptoms questionnaire, bronchoalveolar lavage fluid, and exhaled breath condensate for the identification of lung transplant patients with gastroesophageal reflux disease

Symptoms questionnaire, bronchoalveolar lavage fluid, and exhaled breath condensate for the identification of lung transplant patients with gastroesophageal reflux disease

Christopher S Davis, MD, MPH, Nicholas Reder, MPH, Elizabeth J Kovacs, PhD, P Marco Fisichella, MD

Loyola University Medical Center

Background: Gastroesophageal reflux disease (GERD) is approximately twice as prevalent in patients with end-stage lung disease or after lung transplantation. Recent findings indicate that these patients may be at risk for GERD-related aspiration which may heighten inflammation and hasten the fibrosing process. Furthermore, laparoscopic antireflux surgery (LARS) appears to minimize GERD-related aspiration and to stabilize, if not improve, pulmonary function. Our aim was to determine if measuring bile acids and pepsin in the bronchoalveolar lavage fluid (BALF) and exhaled breath condensate (EBC) is effective for identifying lung transplant patients with GERD.

Methods: From November 2009 to November 2010, 68 lung transplant patients were prospectively enrolled in this study. GERD status was assessed by 24-hour ambulatory pH monitoring, a 21-point symptoms questionnaire was performed, and the levels bile acids and pepsin were measured in the EBC and BALF of patients undergoing surveillance or diagnostic bronchoscopy.

Results: Of the 68 patients, 21 were GERD (+), 12 were GERD (-), and 13 had undergone LARS. All others had not undergone ambulatory pH monitoring. The sensitivity and specificity of BA in the BALF for the presence of GERD were 78% and 82%, respectively. However, the sensitivity and specificity of GERD were < 70% for BA in the EBC and pepsin in the BALF or EBC. The most sensitive item on the symptoms questionnaire for the presence of GERD was coughing (96%), whereas heartburn and belching were also highly sensitive (80% and 88%, respectively). Along these lines, the most specific symptoms for the presence of GERD were dysphagia (77%), odynophagia (90%), chest pain (78%), lump in the throat (78%), hoarseness (76%), laryngitis (100%), aspiration (82%), choking (94%), asthma (100%), bronchitis (100%), and pneumonia (88%).

Conclusions: These data indicate that the measurement of bile acids and pepsin in the BALF and EBC is not, by itself, an effective method to identify lung transplant patients at risk for GERD-related aspiration. We believe that all lung transplant patients should be regarded at risk for GERD, and that identification of candidates for LARS should involve a multimodal approach that includes esophageal function testing, symptoms questionnaires, and assessing the BALF for the presence of pepsin and bile acids.


Session: Poster Presentation

Program Number: P267

79

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals